Tirzepatide represents a groundbreaking therapeutic agent for individuals struggling type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent https://prestonzvrq140247.blog2news.com/41076530/tirzepatide-a-game-changer-for-type-2-diabetes